LifeMD, Inc. operates as a direct-to-patient telehealth company, engages in the provision of patients access to virtual medical care and pharmacy services in the United States. It offers telehealth platform comprising Rex MD, a men’s telehealth platform that provides virtual diagnosis, treatment, and prescription medications for men’s health conditions, including erectile dysfunction, premature ejaculation, hair loss, insomnia, weight loss, and performance anxiety; and ShapiroMD that provides virtual medical treatment, prescription medications, patented doctor formulated OTC products, topical compounded medications, and medical devices treating male and female hair loss. The company also provides LifeMD PC, a virtual primary care and telehealth service which is a provider for their primary care, urgent care, and chronic care needs; and offers virtual medical care, including on-demand consultations and treatment, prescription medications, diagnostics and imaging, wellness coaching, integration with in-home tools, and more. In addition, it offers GLP-1 for weight management and in-home health monitoring devices. The company was formerly known as Conversion Labs, Inc. and changed its name to LifeMD, Inc. in February 2021. LifeMD, Inc. was founded in 1994 and is headquartered in New York, New York.
Telehealth Triumph | LifeMD's Weight Management Program sees explosive growth, doubling subscribers and driving record patient acquisition in Q1 2024 |
Diversification Drive | Explore LifeMD's expansion into men's health with new HRT and weight management offerings, positioning for cross-selling opportunities |
Financial Forecast | Analysts project 35% revenue growth for FY2024, with adjusted EBITDA margins expected to rise from 8% to 13.5% by FY2025 |
AI-Powered Scaling | Learn how LifeMD leverages AI to expand provider capacity and improve drug authorization rates, enhancing operational efficiency |
Metrics to compare | LFMD | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipLFMDPeersSector | |
|---|---|---|---|---|
P/E Ratio | −13.3x | 0.0x | −0.5x | |
PEG Ratio | −0.09 | 0.00 | 0.00 | |
Price/Book | 8.4x | 1.0x | 2.6x | |
Price / LTM Sales | 1.0x | 1.1x | 3.2x | |
Upside (Analyst Target) | 121.7% | 62.1% | 49.3% | |
Fair Value Upside | Unlock | 45.0% | 6.3% | Unlock |